TD Asset Management’s Relay Therapeutics RLAY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $343K | Sell |
99,056
-57,400
| -37% | -$199K | ﹤0.01% | 1151 |
|
|
2025
Q1 | $410K | Hold |
156,456
| – | – | ﹤0.01% | 1163 |
|
|
2024
Q4 | $645K | Sell |
156,456
-30,200
| -16% | -$124K | ﹤0.01% | 1160 |
|
|
2024
Q3 | $1.39M | Sell |
186,656
-19,400
| -9% | -$145K | ﹤0.01% | 1133 |
|
|
2024
Q2 | $1.34M | Sell |
206,056
-152,600
| -43% | -$995K | ﹤0.01% | 1105 |
|
|
2024
Q1 | $2.98M | Sell |
358,656
-109,310
| -23% | -$907K | ﹤0.01% | 906 |
|
|
2023
Q4 | $5.15M | Sell |
467,966
-29,524
| -6% | -$325K | 0.01% | 760 |
|
|
2023
Q3 | $4.18M | Buy |
497,490
+233,983
| +89% | +$1.97M | 0.01% | 771 |
|
|
2023
Q2 | $3.31M | Buy |
263,507
+46,690
| +22% | +$586K | ﹤0.01% | 831 |
|
|
2023
Q1 | $3.57M | Buy |
216,817
+93,255
| +75% | +$1.54M | ﹤0.01% | 828 |
|
|
2022
Q4 | $1.85M | Buy |
123,562
+4,200
| +4% | +$62.7K | ﹤0.01% | 1015 |
|
|
2022
Q3 | $2.76M | Buy |
119,362
+19,365
| +19% | +$448K | ﹤0.01% | 906 |
|
|
2022
Q2 | $1.68M | Hold |
99,997
| – | – | ﹤0.01% | 1058 |
|
|
2022
Q1 | $2.99M | Buy |
99,997
+898
| +0.9% | +$26.9K | ﹤0.01% | 963 |
|
|
2021
Q4 | $3.04M | Buy |
99,099
+72,092
| +267% | +$2.21M | ﹤0.01% | 1023 |
|
|
2021
Q3 | $852K | Buy |
27,007
+4,800
| +22% | +$151K | ﹤0.01% | 1290 |
|
|
2021
Q2 | $720K | Hold |
22,207
| – | – | ﹤0.01% | 1333 |
|
|
2021
Q1 | $768K | Buy |
22,207
+3,867
| +21% | +$134K | ﹤0.01% | 1313 |
|
|
2020
Q4 | $762K | Hold |
18,340
| – | – | ﹤0.01% | 1242 |
|
|
2020
Q3 | $781K | Buy |
+18,340
| New | +$781K | ﹤0.01% | 1133 |
|